Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma

Sarcomas are a heterogeneous group of mesenchymal malignancies. In recent years, studies have demonstrated that inhibition of angiogenic pathways or disruption of established vasculature can attenuate the growth of sarcomas. However, when used as monotherapy in the clinical setting, these targeted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Kieuhoa T., Matthay, Katherine K., DuBois, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896001/
https://www.ncbi.nlm.nih.gov/pubmed/27274393
http://dx.doi.org/10.1186/s13569-016-0049-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896001/
https://www.ncbi.nlm.nih.gov/pubmed/27274393
http://dx.doi.org/10.1186/s13569-016-0049-z

Ejemplares similares